You are here: Industry Insights > UCL

News List

Innovative phase 2 trial targets advanced liver cancer pharmatimes
January 25, 2022
The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of care sorafenib versus the use of sorafenib in isolation。
AstraZeneca and UCL to collaborate on two immuno-oncology projects pharmatimes
February 04, 2021
British drugmaker and researchers from the UCL Division of Infection & Immunity will collaborate on two projects which will aim to contribute to the development of new cancer treatments.
Parkinson’s UK partners with UCL on phase II trial pharmatimes
October 28, 2020
Parkinson’s UK has partnered with University College London (UCL) and will invest £1m in a phase II clinical trial to investigate if the drug ondansetron can alleviate hallucinations in people with Parkinson’s disease.
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds pharmatimes
August 07, 2020
Research co-led by UCL and the London School of Hygiene & Tropical Medicine has found that a second COVID-19 wave can be prevented if testing and tracing is scale-up in the UK.
MSD's Keytruda doubles PFS in bowel cancer subset pharmatimes
May 29, 2020
MSD's immunotherapy Keytruda (pembrolizumab) more than doubled progression free survival in patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
Eisai, UCL extend neuro pact, gear up for Alzheimer’s phase 1 fiercebiotech
December 28, 2018
Six years after Eisai and University College London teamed up to discover new treatments for neurological diseases, they are moving their first candidate into the clinic.....
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody expressbpd
December 10, 2018
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody
Eisai and UCL deepen drug discovery alliance pharmaceutical-technology
December 10, 2018
Japanese pharmaceutical company Eisai has expanded its drug discovery collaboration with University College London (UCL) in the UK for additional five years to 2023......
First Alzheimer's drug from Eisai/UCL alliance to enter clinical trials pharmatimes
December 07, 2018
The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.
Lilly streams £5m into virtual lab pact with UCL, Imperial pharmatimes
September 13, 2018
Imperial College London, UCL and Eli Lilly have formed an alliance that strives to transform medicines manufacturing in England.

Previous page 1 2 Next page